This inventor holds 1 USPTO granted patent. Top assignees: Centocor, Inc., New York University. Active years: 2007.
Company Filing History:
1 out of 144 
1 out of 1,726 
Years Active: 2007
Title: John Ghraveb: Innovator in Rheumatoid Arthritis Treatment
Introduction
John Ghraveb is a notable inventor based in Thorndale, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of rheumatoid arthritis. His innovative work has led to the development of methods that utilize anti-TNF antibodies for therapeutic purposes.
Latest Patents
Ghraveb holds a patent for "Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies." This patent encompasses anti-TNF antibodies, fragments, and regions that are specific for human tumor necrosis factor-α (TNFα). These innovations are useful in the in vivo diagnosis and therapy of various TNFα-mediated pathologies and conditions. The patent also includes polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, and methods of using the anti-TNF antibody or its derivatives in immunoassays and immunotherapeutic approaches.
Career Highlights
Throughout his career, Ghraveb has worked with prestigious institutions, including New York University and Centocor, Inc. His experience in these organizations has allowed him to advance his research and contribute to the medical field significantly.
Collaborations
Ghraveb has collaborated with notable colleagues such as Junming Le and Jan T Vilcek. These partnerships have further enriched his research and development efforts in the field of immunotherapy.
Conclusion
John Ghraveb's innovative work in the treatment of rheumatoid arthritis through the use of anti-TNF antibodies showcases his dedication to advancing medical science. His contributions have the potential to improve the lives of many individuals suffering from TNFα-mediated conditions.